Clinical Trial Update: Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update showing Tenecteplase reperfusion therapy for acute ischemic cerebrovascular events is currently recruiting in the BEYOND study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke | Phase 3 | Status: RECRUITING